# Velsera (Seven Bridges and Pierian)

Source: https://onco.cc/companies/velsera/  
OnCo record `velsera` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Genomics cloud and clinical interpretation company formed from Seven Bridges, Pierian, and UgenTec in 2023; operates the NCI Cancer Genomics Cloud.

## Summary

Velsera, based in Boston, is a genomics cloud and clinical interpretation company formed in 2023 from Seven Bridges, Pierian and UgenTec, and it operates the NCI Cancer Genomics Cloud. It provides a bioinformatics platform for research and for clinical next-generation sequencing reporting. OnCo links it to clinical NGS bioinformatics and variant interpretation and to genomics cloud and secure research environments. Whether a merged research and clinical platform serves either market as well as the specialists did is the open question. The genomics cloud technology page carries the wider picture.

## Fields

- Kind: Company
- Last checked: 2026-09-08
- Tags: supporting
- HQ: Boston, MA
- Type: ai-software
- Website: https://velsera.com

## Sources

- Official website: https://velsera.com

## Connected records

- fronts: [AI & Computation](https://onco.cc/fronts/ai-computation/), [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/)
- technologies: [Clinical NGS bioinformatics and variant interpretation](https://onco.cc/technologies/ngs-bioinformatics-software/), [Genomics cloud and secure research environments](https://onco.cc/technologies/genomics-cloud-platforms/)

---
JSON: https://onco.cc/api/v1/entities/velsera.json